1Heath D, Edwards J. Oberaltions on the pathogenesis and management pulmonary hypertension, Circulation, 1958,118: 533.
2Muller WH, Obervations on the pathogenesis and management of pulmonary hypertension, Am J Surg, 1978,135:302-311.
3Everett AD, Le Cras TD, Xue C, et al. eNOS expression is not altered in pulmonary vascular remodeling due to increased pulmonary blood flow, Am J Physiol, 1998, 274:1058-1065.
6Levy M, Maurey C, Celermajer DS, et al. Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. Coll Cardiol, 2007, 49(7): 803.
7Stenmark KR, McMurtry IF. Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal? Circ Res, 2005, 97(2) :95.
9Austin ED, Loyd JE. Genetics and mediators in pulmonary arterial hypertension. Clin Chest Med, 2007, 28(1): 43.
10Neuss S, Becher E, Woltje M, et al. Functional expression of HGF and HGF receptor/c-met in adult human mesenehymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells, 2004, 22(3): 405.
